Dr Rebecca Beeken wants to see if a diet programme that has been beneficial in other diseases could also benefit overweight women with breast cancer.

Professor David French would like to understand whether for women at low risk of breast cancer, the benefits of screening outweigh the potential harms, and if so, whether these women should be offered less frequent screening appointments.

In the future, breast screening could be adapted to a woman’s personal risk of developing breast cancer, which could change how regularly women are screened. Dr Jo Waller will investigate the concerns women have about this to ensure these approaches are effective.

Professor Ian Kunkler is investigating the impact that an additional, targeted booster dose of radiotherapy has on preventing DCIS from returning and developing into invasive breast cancer, and the effects it has on breast appearance and quality of life.

People with ER positive breast cancer can be prescribed anti-hormone treatment for five years or more to reduce the risk of recurrence, but many find it hard to complete the course. Dr Hughes’ team are developing a way to help people persist with their treatment.

 

For some patients with certain types of breast cancer, treatment with radiotherapy (x-ray treatment) and hormone therapy before surgery may reduce the need for mastectomies (removal of the whole breast) and allow breast conserving surgery (removal of a small part of the breast) instead. Reducing the need for mastectomies is likely to improve patient well-being.